Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
11.92
+0.38 (3.29%)
Oct 15, 2025, 4:00 PM EDT - Market closed
Exagen Market Cap
Exagen has a market cap or net worth of $262.28 million as of October 15, 2025. Its market cap has increased by 380.43% in one year.
Market Cap
262.28M
Enterprise Value
257.55M
1-Year Change
380.43%
Ranking
Category
Stock Price
$11.92
Market Cap Chart
Since September 19, 2019, Exagen's market cap has increased from $63.11M to $262.28M, an increase of 315.63%. That is a compound annual growth rate of 26.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 253.92M | 251.14% |
| Dec 31, 2024 | 72.31M | 113.18% |
| Dec 29, 2023 | 33.92M | -13.39% |
| Dec 30, 2022 | 39.17M | -79.17% |
| Dec 31, 2021 | 187.99M | 12.56% |
| Dec 31, 2020 | 167.01M | -47.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 728.96B |
| Johnson & Johnson | 451.35B |
| AbbVie | 405.41B |
| UnitedHealth Group | 321.51B |
| AstraZeneca | 263.00B |
| Novo Nordisk | 257.10B |
| Novartis AG | 251.30B |
| Abbott Laboratories | 229.72B |